vs

Side-by-side financial comparison of BLACK HILLS CORP (BKH) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

BLACK HILLS CORP is the larger business by last-quarter revenue ($241.6M vs $121.8M, roughly 2.0× Core Laboratories Inc.). BLACK HILLS CORP runs the higher net margin — 55.1% vs 4.2%, a 50.9% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (-1.4% vs -3.0%). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -22.0%).

Black Hills Corporation is an American diversified energy company that is an electric and gas utility in South Dakota, Montana, Wyoming, Colorado, Arkansas, Kansas, Nebraska, and Iowa. The company sells power throughout the American West. The company is based in Rapid City, South Dakota. It derives its name from its home in the Black Hills of South Dakota.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

BKH vs CLB — Head-to-Head

Bigger by revenue
BKH
BKH
2.0× larger
BKH
$241.6M
$121.8M
CLB
Growing faster (revenue YoY)
CLB
CLB
+1.6% gap
CLB
-1.4%
-3.0%
BKH
Higher net margin
BKH
BKH
50.9% more per $
BKH
55.1%
4.2%
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-22.0%
BKH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BKH
BKH
CLB
CLB
Revenue
$241.6M
$121.8M
Net Profit
$133.1M
$5.1M
Gross Margin
Operating Margin
83.6%
1.5%
Net Margin
55.1%
4.2%
Revenue YoY
-3.0%
-1.4%
Net Profit YoY
-2.4%
EPS (diluted)
$1.73
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKH
BKH
CLB
CLB
Q1 26
$241.6M
$121.8M
Q4 25
$622.7M
$138.3M
Q3 25
$427.4M
$134.5M
Q2 25
$435.7M
$130.2M
Q1 25
$800.4M
$123.6M
Q4 24
$585.1M
$129.2M
Q3 24
$398.6M
$134.4M
Q2 24
$397.1M
$130.6M
Net Profit
BKH
BKH
CLB
CLB
Q1 26
$133.1M
$5.1M
Q4 25
$104.9M
$4.9M
Q3 25
$24.9M
$14.2M
Q2 25
$27.5M
$10.6M
Q1 25
$134.3M
$-154.0K
Q4 24
$98.0M
$7.4M
Q3 24
$24.4M
$11.7M
Q2 24
$22.8M
$9.0M
Gross Margin
BKH
BKH
CLB
CLB
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
BKH
BKH
CLB
CLB
Q1 26
83.6%
1.5%
Q4 25
27.5%
11.5%
Q3 25
18.4%
15.6%
Q2 25
18.9%
11.7%
Q1 25
25.6%
3.6%
Q4 24
27.9%
11.0%
Q3 24
19.0%
14.7%
Q2 24
17.8%
12.3%
Net Margin
BKH
BKH
CLB
CLB
Q1 26
55.1%
4.2%
Q4 25
16.8%
3.6%
Q3 25
5.8%
10.6%
Q2 25
6.3%
8.2%
Q1 25
16.8%
-0.1%
Q4 24
16.7%
5.7%
Q3 24
6.1%
8.7%
Q2 24
5.7%
6.9%
EPS (diluted)
BKH
BKH
CLB
CLB
Q1 26
$1.73
$0.11
Q4 25
$1.39
$0.11
Q3 25
$0.34
$0.30
Q2 25
$0.38
$0.22
Q1 25
$1.87
$0.00
Q4 24
$1.36
$0.15
Q3 24
$0.35
$0.25
Q2 24
$0.33
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKH
BKH
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
Total Assets
$587.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKH
BKH
CLB
CLB
Q1 26
$22.8M
Q4 25
$182.8M
$22.7M
Q3 25
$21.1M
$25.6M
Q2 25
$8.1M
$31.2M
Q1 25
$6.6M
$22.1M
Q4 24
$16.1M
$19.2M
Q3 24
$12.5M
$21.5M
Q2 24
$624.8M
$17.7M
Total Debt
BKH
BKH
CLB
CLB
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
BKH
BKH
CLB
CLB
Q1 26
$275.1M
Q4 25
$3.8B
$266.0M
Q3 25
$3.8B
$271.3M
Q2 25
$3.6B
$261.3M
Q1 25
$3.6B
$253.4M
Q4 24
$3.5B
$246.6M
Q3 24
$3.4B
$250.7M
Q2 24
$3.4B
$240.3M
Total Assets
BKH
BKH
CLB
CLB
Q1 26
$587.7M
Q4 25
$10.9B
$584.0M
Q3 25
$10.3B
$591.4M
Q2 25
$10.1B
$602.1M
Q1 25
$10.1B
$591.5M
Q4 24
$10.0B
$585.1M
Q3 24
$9.7B
$600.5M
Q2 24
$10.2B
$597.8M
Debt / Equity
BKH
BKH
CLB
CLB
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKH
BKH
CLB
CLB
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKH
BKH
CLB
CLB
Q1 26
$4.0M
Q4 25
$168.1M
$7.9M
Q3 25
$88.9M
$8.5M
Q2 25
$188.6M
$13.9M
Q1 25
$227.8M
$6.7M
Q4 24
$153.2M
$20.6M
Q3 24
$102.1M
$13.1M
Q2 24
$230.6M
$17.1M
Free Cash Flow
BKH
BKH
CLB
CLB
Q1 26
$517.0K
Q4 25
$-101.5M
$5.0M
Q3 25
$-89.5M
$6.5M
Q2 25
$-30.3M
$10.4M
Q1 25
$74.9M
$3.9M
Q4 24
$-60.5M
$17.4M
Q3 24
$-86.0M
$10.4M
Q2 24
$64.4M
$14.3M
FCF Margin
BKH
BKH
CLB
CLB
Q1 26
0.4%
Q4 25
-16.3%
3.6%
Q3 25
-20.9%
4.8%
Q2 25
-7.0%
8.0%
Q1 25
9.4%
3.1%
Q4 24
-10.3%
13.4%
Q3 24
-21.6%
7.7%
Q2 24
16.2%
10.9%
Capex Intensity
BKH
BKH
CLB
CLB
Q1 26
Q4 25
43.3%
2.1%
Q3 25
41.7%
1.5%
Q2 25
50.2%
2.7%
Q1 25
19.1%
2.3%
Q4 24
36.5%
2.5%
Q3 24
47.2%
2.0%
Q2 24
41.9%
2.2%
Cash Conversion
BKH
BKH
CLB
CLB
Q1 26
0.77×
Q4 25
1.60×
1.61×
Q3 25
3.57×
0.60×
Q2 25
6.86×
1.31×
Q1 25
1.70×
Q4 24
1.56×
2.78×
Q3 24
4.18×
1.12×
Q2 24
10.11×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons